Hugel company information, Employees & Contact Information

Hugel Inc. appoints Carrie Strom as Chief Executive Officer PR Newswire

Hugel hosts global H.E.L.F. symposium, marking 15 years of botulinum toxin Letybo PR Newswire

Hugel wins UAE approval for botulinum toxin Botulax Yahoo Finance

Hugel launches botulinum toxin Letybo in Malaysia PR Newswire

Hugel achieves record net sales, profit, net income in 2024 Yahoo Finance

Hugel strengthens Brazil presence with Letybo launch and new partner Derma Dream PR Newswire

Firm Advises CBC Group in Acquisition of Significant Equity Interests in Hugel, Inc. Wilson Sonsini

Hugel posts record first-half net sales exceeding KRW200 billion in H1 2025 PR Newswire

Hugel's skincare brand WELLAGE joins K-beauty festival in New York Yahoo Finance

Hugel posts KRW89.8 billion in net sales, marking record Q1 earnings PR Newswire

Hugel hits record net sales, operating profit in Q3 Yahoo Finance

BENEV Company, Inc. and Hugel Inc. are pleased to announce that Letybo® (letibotulinumtoxinA-wlbg) is now fully commercialized in the U.S., marking a significant milestone in the neuromodulator market PR Newswire

Hugel vows to become global leader at J.P. Morgan Healthcare Conference PR Newswire

Hugel and Medica join forces to boost botulinum toxin sales in Middle East, North Africa PR Newswire

Hugel Inc. and BENEV Company Inc. Announce Strategic Partnership in the U.S. Market PR Newswire

Hugel Achieves Record-High Revenue and Operating Profit PR Newswire

ITC final initial determination Ruled in favor of Hugel (no violation of Section 337) PR Newswire

Hugel Receives FDA Approval in the United States of Letybo (letibotulinumtoxinA-wlbg) for Injection for the Treatment of Glabellar Lines PR Newswire

Hugel America, Inc. Announces Successful Completion of Croma-Pharma’s Decentralized Procedure for Letybo Business Wire

Hugel Names Former Allergan Aesthetics President Carrie Strom as Global CEO Global Cosmetics News

Hugel Appoints Daniel Chang as New CEO Businesskorea

Hugel America, Inc. Announces U.S. FDA Acceptance of Biologics License Application (BLA) for LetibotulinumtoxinA for Injection to Treat Glabellar (Frown) Lines PR Newswire

Hugel's botulinum toxin wins approval in Austria The Korea Herald

Hugel resubmits application to FDA for botulinum toxin product The Korea Economic Daily Global Edition

Hugel names ex-CEO of LG Household & Health Care as chairman The Korea Economic Daily Global Edition

Medytox files complaint with ITC against Hugel over botox strain The Korea Economic Daily Global Edition

Hugel's botulinum toxin Botulax makes UAE debut The Korea Herald

Hugel Appoints Carrie Strom as Global CEO Businesskorea

Hugel accelerates European botox sales with Poland's approval The Korea Economic Daily Global Edition

GS ups spending to take control of botox maker Hugel The Korea Economic Daily Global Edition

CBC-Led Consortium Buys Bain’s Hugel Stake For $1.5 Billion Bloomberg.com

US calls on 2 S.Korean pharmaceutical companies for swift end to legal battle The Korea Economic Daily Global Edition

Behind the scenes of GS-led group's $1.5 bn Hugel purchase The Korea Economic Daily Global Edition

Korean medical aesthetic firm Hugel launches botulinum toxin Letybo in Malaysia BioSpectrum Asia

S. Korean botox maker Hugel to enter US market this year The Korea Herald

Bain Capital sells management rights of Hugel to GS-led group for $1.5 bn The Korea Economic Daily Global Edition

Samsung looks to acquire bio company, reviews botox maker Hugel The Korea Economic Daily Global Edition

Americraft Marine Group Names Hugel CFO Marine News Magazine

Mubadala joins GS-led group to buy Korean botox maker The Korea Economic Daily Global Edition

Daily Brief South Korea: Hugel Inc, KT Corp, Cosmochemical, CUBox and more Smartkarma